Examining how new hospice drug policies affect costs and medication use for patients.
Official title: Impact of New Hospice Drug Policies on Expenditures, Utilization, Prescribing Quality, and Access
Funded at Univ of Massachusetts Med Sch Worcester · NIH-10981308 · Data updated 2026-11-12
This study is looking at how new rules about medications in hospice care are affecting the costs and prescriptions for older Americans, so we can better understand how these changes impact patients and hospice providers.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of Massachusetts Med Sch Worcester NIH-funded |
| Lab location | 1 site (Worcester, United States) |
| Project start | September 30, 2024 |
| Project end | July 31, 2029 |
| Funding year | 2024 |
| Award (this year) | $400,000 |
| NIH project number | 1R01HS029507-01A1 |
| Project ID | NIH-10981308 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are older adults aged 65 and over who are currently receiving hospice services.
✕Less likely to help
Patients who are not enrolled in Medicare or those who do not utilize hospice services may not benefit from this research.
What this research studies
This research investigates the effects of recent changes in hospice drug policies on medication expenditures and prescribing practices for older Americans receiving hospice care. By analyzing data from Medicare, the study aims to understand how these policy shifts impact both patients and hospice agencies. The researchers will look at medication utilization patterns before and after the policy changes to identify any significant trends or issues that arise from these new regulations.
Why it matters
Potential benefit: If successful, this research could lead to improved medication management and access for hospice patients, ensuring they receive necessary treatments without unnecessary financial burdens.
How similar studies have gone: While there have been studies on hospice care and medication management, this specific analysis of the impact of policy changes on expenditures and prescribing quality is relatively novel.
Where this research is happening
-
Univ of Massachusetts Med Sch Worcester
Worcester, United States Active
Researchers
- Principal investigator: Tjia, Jennifer — Univ of Massachusetts Med Sch Worcester
- Study coordinator: Tjia, Jennifer
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.